AKT1 and hepatocellular carcinoma: In summary, we have demonstrated that usenamine A inhibited ID1 expression by downregulating AKT/mTOR/STAT3 signaling and fostering ubiquitin–proteasome-mediated ID1 degradation in human HCC cells (Fig. 9).